Blockchain Registration Transaction Record

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Reversing Cellular Aging

Telomir Pharmaceuticals announces Telomir-1's success in preclinical studies against cellular aging, offering new hope for progeria and longevity science.

Telomir Pharmaceuticals' Telomir-1 Shows Promise in Reversing Cellular Aging

This news is significant as it highlights a potential breakthrough in treating Hutchinson-Gilford Progeria Syndrome (HGPS) and possibly other age-related diseases. Telomir-1's ability to address the molecular mechanisms of aging could pave the way for treatments that not only extend life but improve its quality, offering hope to patients with progeria and potentially benefiting the broader aging population.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x7ec00f31472d6d79ba9f7e30bfc278d1ae21bceb5029d5e8f8b5be9d7db26e99
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintenvyZVK1-3f5395861fbbf321ec07262437f60745